Aptose Biosciences Files S-1 for Stock Offering

TL;DR

Aptose (APTO) filed an S-1, looks like they're prepping to sell more stock.

AI Summary

Aptose Biosciences Inc. filed an S-1 registration statement on August 1, 2024, to register an unspecified number of common shares. The company, formerly Lorus Therapeutics Inc., is incorporated in Canada and headquartered in Toronto. This filing indicates potential future stock offerings to raise capital for its operations, which are in the biological products sector.

Why It Matters

This S-1 filing signals Aptose Biosciences' intent to potentially raise capital through the sale of its stock, which could impact its financial structure and future development plans.

Risk Assessment

Risk Level: medium — As a biotechnology company filing an S-1, Aptose is likely seeking capital for drug development, which inherently carries significant financial and clinical risks.

Key Players & Entities

• Aptose Biosciences Inc. (company) — Registrant
• Lorus Therapeutics Inc. (company) — Former company name
• August 1, 2024 (date) — Filing date
• Canada (location) — Jurisdiction of incorporation
• Toronto (location) — Principal executive office location

FAQ

Key Financial Figures

• $0.567 — rice of the common shares on Nasdaq was $0.567 per common share and on the TSX was C$0
• $0.76 — 67 per common share and on the TSX was C$0.76 per common share. [We have applied to t

Filing Documents

• d878566ds1.htm (S-1) — 286KB
• d878566dex231.htm (EX-23.1) — 4KB
• d878566dexfilingfees.htm (EX-FILING FEES) — 17KB
• g878566g00h01.jpg (GRAPHIC) — 39KB
• g878566g0801172147431.jpg (GRAPHIC) — 2KB
• 0001193125-24-191837.txt ( ) — 365KB

DILUTION

DILUTION 10 PLAN OF DISTRIBUTION 11 CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS 14 DESCRIPTION OF OUR COMMON SHARES 23 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES 25 LEGAL MATTERS 25 EXPERTS 25 WHERE YOU CAN FIND MORE INFORMATION 25 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 26 Table of Contents ABOUT THIS PROSPECTUS This prospectus, including the information incorporated by reference, is part of a registration statement that we have filed with the Securities and Exchange Commission (the SEC). You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus, including the Information Incorporated by Reference herein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you under the captions Where You Can Find More Information and Incorporation of Certain Information by Reference in this prospectus. Neither we nor the Placement Agent have authorized any dealer, salesman or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any of our securities other than the securities covered hereby, nor does this prospectus constitute an offer to sell or the solicitation

financial statements, or cause us to fail to meet our reporting obligations or fail to prevent fraud;

financial statements, or cause us to fail to meet our reporting obligations or fail to prevent fraud; our broad discretion in how we use the proceeds of the sale of Offered Shares our ability to expand our business through the acquisition of companies or businesses; and other risks detailed from time-to-time in our on-going filings with the SEC and Canadian securities regulators, and those which are discussed under the heading Risk Factors in this prospectus and in the documents incorporated by reference. Should one or more of these risks or uncertainties materialize, or should the assumptions described in the sections entitled Risk Factors in this prospectus and in the documents incorporated by reference underlying those forward-looking statements prove incorrect, actual results may vary materially from those described in the forward-looking statements. More detailed information about these and other factors is included in this prospectus under the section entitled Risk Factors and in the documents incorporated by reference into this prospectus. Although we have iii Table of Contents attempted to identify factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Forward-looking statements are based upon our beliefs, estimates and opinions at the time they are made and we undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or circumstances should change, except as required by applicable law. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this prospectus a

View Full Filing

View this S-1 filing on SEC EDGAR